Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

OBJECTIVES: Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time. STUDY DESIGN: We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Busse, Clara E., Latour, Chase D., Dejene, Sara Z., Knittel, Andrea K., Wood, Mollie E., Kinlaw, Alan C., Dissanayake, Mekhala V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562738/
https://www.ncbi.nlm.nih.gov/pubmed/37823033
http://dx.doi.org/10.1016/j.conx.2023.100101
Descripción
Sumario:OBJECTIVES: Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time. STUDY DESIGN: We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions. RESULTS: The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time. CONCLUSIONS: LARCs are increasingly popular forms of contraception among commercially insured individuals. IMPLICATIONS: Given the increasing popularity, ensuring access to LARCs is critical.

Ejemplares similares